Marie Wislez

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study

Franck Morin, Patrick Merle, Pascal Auquier, 2018, European Respiratory Journal.

Murine Lung Tumor Measurement Using Respiratory-Gated Micro-Computed Tomography

B Nebiyou Bekele, Dianna D Cody, Roger E Price, 2005, Investigative radiology.

Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

A. Furlan, M. Wislez, D. Tulasne, 2017, Journal of the National Cancer Institute.

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras

Lin Ji, Yanan Yang, Ignacio Wistuba, 2008, Molecular Cancer Therapeutics.

Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells

Jie Zhang, Ignacio I. Wistuba, Wei Wei, 2008, Cancer Prevention Research.

Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer.

Mu Hu, Lei Wang, Huaiyin Shi, 2015, Biochemical and biophysical research communications.